Michael R Law

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia
    Michael R Law
    Department of Ambulatory Care and Prevention, Harvard Medical School, and Harvard Pilgrim Health Care, Boston, Mass 02215, USA
    J Clin Psychiatry 69:47-53. 2008
  2. ncbi Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements
    Michael R Law
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
    Psychiatr Serv 59:540-6. 2008
  3. ncbi Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 33:135-44. 2011
  4. ncbi Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study
    Michael R Law
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 32:729-41; discussion 716. 2010
  5. ncbi Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change
    Stephen B Soumerai
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, in Boston, Massachusetts, USA
    Health Aff (Millwood) 27:w185-95. 2008
  6. ncbi Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
    Michael R Law
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA
    BMJ 337:a1055. 2008
  7. ncbi Cost-effectiveness of schizophrenia pharmacotherapy
    Stephen B Soumerai
    Am J Psychiatry 164:678; author reply 678-9. 2007

Detail Information

Publications7

  1. ncbi A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia
    Michael R Law
    Department of Ambulatory Care and Prevention, Harvard Medical School, and Harvard Pilgrim Health Care, Boston, Mass 02215, USA
    J Clin Psychiatry 69:47-53. 2008
    ..However, such analyses typically measure adherence averaged over long time periods. We investigated the temporal relationship between nonadherence and hospitalization risk using a daily measure of medication availability...
  2. ncbi Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements
    Michael R Law
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
    Psychiatr Serv 59:540-6. 2008
    ..Twenty-two states restrict particular dosing forms (injections). This study examined the impact of such restrictions...
  3. ncbi Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 33:135-44. 2011
    ..Some Medicaid programs have adopted prior-authorization (PA) policies that require prescribers to request approval from Medicaid before prescribing drugs not included on a preferred drug list...
  4. ncbi Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study
    Michael R Law
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 32:729-41; discussion 716. 2010
    ..However, little is known about the impact of these policies on the use of antihypertensive medicines in the United States...
  5. ncbi Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change
    Stephen B Soumerai
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, in Boston, Massachusetts, USA
    Health Aff (Millwood) 27:w185-95. 2008
    ..AA spending was slightly lower in both states. Observed increases in treatment discontinuities without cost savings suggest that AAs should be exempt from PA for patients with severe mental illnesses...
  6. ncbi Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
    Michael R Law
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA
    BMJ 337:a1055. 2008
    ..To assess the impact of direct to consumer advertising of prescription drugs in the United States on Canadian prescribing rates for three heavily marketed drugs-etanercept, mometasone, and tegaserod...
  7. ncbi Cost-effectiveness of schizophrenia pharmacotherapy
    Stephen B Soumerai
    Am J Psychiatry 164:678; author reply 678-9. 2007